HC Wainwright Issues Positive Estimate for LXRX Earnings
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) – Analysts at HC Wainwright boosted their Q2 2025 EPS estimates for Lexicon Pharmaceuticals in a note issued to investors on Wednesday, May 14th. HC Wainwright analyst J. Pantginis now anticipates that the biopharmaceutical company will earn ($0.08) per share for the quarter, up from their prior estimate […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) – Analysts at HC Wainwright boosted their Q2 2025 EPS estimates for Lexicon Pharmaceuticals in a note issued to investors on Wednesday, May 14th. HC Wainwright analyst J. Pantginis now anticipates that the biopharmaceutical company will earn ($0.08) per share for the quarter, up from their prior estimate […]
